GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Pre-Market Trading 11-22 06:43:35 EST

72.07

+2.69

+3.88%

盘前73.97

+1.90+2.64%

06:11 EST

High75.49	Low69.00	Vol675.48K
Open69.16	D1 Closing69.38	Amplitude9.35%
Mkt Cap1.98B	Tradable Cap1.35B	Total Shares27.47M
T/O49.37M	T/O Rate3.60%	Tradable Shares18.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":72.07,"timestamp":1732222800000,"preClose":69.38,"halted":0,"volume":675482,"hourTrading":{"tag":"盘前","latestPrice":73.97,"preClose":72.07,"latestTime":"06:11 EST","volume":28,"amount":2070.7299199999998,"timestamp":1732273872297},"delay":0,"floatShares":18769702,"shares":27471397,"eps":-3.159844,"marketStatus":"Pre-Market Trading","change":2.69,"latestTime":"11-22 06:43:35 EST","open":69.16,"high":75.4899,"low":69.0001,"amount":49373239.542771995,"amplitude":0.09354,"askPrice":77.88,"askSize":8,"bidPrice":65.5,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.159844,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1732285800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":72.07,"preHourTrading":{"tag":"盘前","latestPrice":73.97,"preClose":72.07,"latestTime":"06:11 EST","volume":28,"amount":2070.7299199999998,"timestamp":1732273872297},"postHourTrading":{"tag":"盘后","latestPrice":73,"preClose":72.07,"latestTime":"19:40 EST","volume":6755,"amount":488209.98,"timestamp":1732236030857},"volumeRatio":1.1348553619443242,"impliedVol":0.8169,"impliedVolPercentile":0.1793},"requestUrl":"/m/hq/s/WGS/wiki","defaultTab":"wiki","newsList":[{"id":"2484944779","title":"GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover","url":"https://stock-news.laohu8.com/highlight/detail?id=2484944779","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484944779?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:30","pubTimestamp":1732023000,"startTime":"0","endTime":"0","summary":"New Biopharma Solution Aims to Accelerate the Delivery of Precision Medicine to More Patients. STAMFORD, Conn., November 19, 2024----GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced GeneDx Discover, a first-of-its-kind data visualization tool, which provides biopharmaceutical companies access to deidentified and aggregated genetic data - powered by GeneDx’s robust database - to improve all stages of drug development. The new offering is part of GeneDx’s ongoing investment to deliver personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery.GeneDx Discover is a self-service tool which leverages real-world data to enable a deeper understanding of the characteristics of target patient populations. The easy-to-use tool combines disease prevalence and phenotypic information, alongside variant-level details, unlocking a deeper understanding of the size and unique characteristics of the total","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7XozH5QZ.KwVQweYXLwSfQ--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f059955720155635b7574b5a3789c8a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7XozH5QZ.KwVQweYXLwSfQ--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f059955720155635b7574b5a3789c8a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-fuels-rare-disease-drug-133000924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WGSWW","WGS","BK4196"],"gpt_icon":0},{"id":"2484676055","title":"BRIEF-GeneDx Announces Heidi Chen As Chief Legal Officer And Corporate Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676055","media":"Reuters","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484676055?lang=en_us&edition=fundamental","pubTime":"2024-11-18 22:48","pubTimestamp":1731941325,"startTime":"0","endTime":"0","summary":"Nov 18 (Reuters) - GeneDx Holdings Corp   :   * GENEDX ANNOUNCES HEIDI CHEN AS CHIEF LEGAL OFFICER AND CORPORATE SECRETARYSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2484999620","title":"GeneDx appoints Heidi Chen as chief legal officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484999620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484999620?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:35","pubTimestamp":1731936919,"startTime":"0","endTime":"0","summary":"GeneDx (WGS) announced the appointment of Heidi Chen as chief legal officer, effective November 25. In her role, Heidi will report to Katherine Stu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genedx-appoints-heidi-chen-as-chief-legal-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genedx-appoints-heidi-chen-as-chief-legal-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2484627299","title":"GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484627299?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:30","pubTimestamp":1731936602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA1PG19D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2484832678","title":"GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2484832678","media":"Business Wire","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484832678?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:30","pubTimestamp":1731936600,"startTime":"0","endTime":"0","summary":"Veteran Legal Executive from Zoetis and Pfizer Joins GeneDx Executive Leadership Team to Lead Legal, Compliance and Policy Functions. STAMFORD, Conn., November 18, 2024----GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Heidi Chen as Chief Legal Officer, effective November 25, 2024. In her role, Heidi will report to Katherine Stueland, CEO and President, and will serve on the executive leadership team.With over 30 years of experience, Heidi will lead all legal, compliance, and policy functions at GeneDx and will provide strategic counsel on corporate governance, intellectual property, regulatory matters, federal policy, compliance and more.About GeneDx:GeneDx  delivers personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xe0YFzhIycTZKGTMM2L0.w--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/b41c7f6806c94fbc201f97fa206dddba","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xe0YFzhIycTZKGTMM2L0.w--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/b41c7f6806c94fbc201f97fa206dddba"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-announces-heidi-chen-chief-133000757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","IE00B19Z3581.USD","LU0868494617.USD","SG9999001176.SGD","LU0306807586.USD","LU0234572021.USD","SG9999002224.SGD","LU1894683264.USD","SG9999003800.SGD","LU0985481810.HKD","LU0321505439.SGD","LU0321505868.SGD","LU0456855351.SGD","BK4592","BK4534","LU1057294990.SGD","PFE","BK4585","LU1066051498.USD","SG9999002232.USD","IE0002270589.USD","LU0058720904.USD","SG9999001176.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU1894683348.USD","BK4588","LU0225284248.USD","BK4007","BK4550","IE00BBT3K403.USD","LU0122379950.USD","SGXZ57979304.SGD","WGS","LU1066053197.SGD","LU1023059063.AUD","LU0170899867.USD","BK4568","LU0225771236.USD","LU1883839398.USD","LU0306806265.USD","SG9999011175.SGD","IE00BLSP4239.USD","SG9999013999.USD","LU0289739699.SGD","IE00BLSP4452.SGD","BK4581","WGSWW"],"gpt_icon":1},{"id":"2482451893","title":"Southwest Airlines, Samsara, Nathan's, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2482451893","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482451893?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:45","pubTimestamp":1731102300,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Oct. 31 through Nov. 6, 2024. Source: VerityData. Following the sale, ISMMS continues to own 10.4% of GeneDx Holdings' outstanding stock. GeneDx shares have rocketed this year to a recent price of over $79 from a close of $2.75 on the last trading day of 2023. In late October, CEO Katherine Stueland noted that GeneDx achieved profitability in the third quarter.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISBC","BK4008","NATH","BK4209","IOT","LUV","MLI","BK4161","WGS","BK4500","BK4588","BK4196","BK4023","BK4585","BK4211"],"gpt_icon":0},{"id":"2481783861","title":"BRIEF-Alphabet Cuts Share Stake In Snowflake, Ups In Freshworks, Dissolves In Illumina","url":"https://stock-news.laohu8.com/highlight/detail?id=2481783861","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481783861?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:26","pubTimestamp":1731065171,"startTime":"0","endTime":"0","summary":"BRIEF-Alphabet Cuts Share Stake In Snowflake, Ups In Freshworks, Dissolves In Illumina Nov 8 (Reuters) - Alphabet Inc GOOGL.O:ALPHABET REPORTS SHARE STAKE OF 22,711 SHARES IN GENEDX - SEC FILINGALPHAB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3MF1MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0056508442.USD","BK4538","BK4554","LU0130517989.USD","WGS","BK4503","LU0061474960.USD","BK4535","LU0187121727.USD","LU0128525689.USD","LU0096364046.USD","IE0004091025.USD","LU0130102774.USD","SNOW","IE00B1BXHZ80.USD","LU0130103400.USD","BK4561","BK4581","IE00BKVL7J92.USD","LU0080751232.USD","BK4077","BK4574","LU0158827781.USD","BK4566","LU1923623000.USD","IE00BK4W5M84.HKD","FRSH","LU0128525929.USD","BK4579","LU0097036916.USD","BK4532","LU0215105999.USD","IE0034235303.USD","IE00BJTD4N35.SGD","LU0061474705.USD","LU1951200564.SGD","LU0029864427.USD","BK4023","ILMN","LU0106261372.USD","LU0048573561.USD","GOOGL","LU0211327993.USD","BK4533","LU0130518102.USD","IE00BJLML261.HKD","BK4534","BK4514","LU1951198990.SGD","LU0149725797.USD"],"gpt_icon":1},{"id":"2481272451","title":"Alphabet Reports Share Stake of 22,711 Shares in GeneDx - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2481272451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481272451?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:10","pubTimestamp":1731064243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3MF1MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0061475181.USD","BK4576","IE00B1BXHZ80.USD","LU0096362180.USD","BK4196","LU0097036916.USD","LU0128525929.USD","LU0130102774.USD","BK4585","BK4503","LU0096364046.USD","BK4566","BK4527","LU0029864427.USD","BK4533","LU0061474705.USD","IE00BJTD4V19.USD","LU0215105999.USD","IE00BK4W5M84.HKD","LU0077335932.USD","LU0061474960.USD","LU0154236417.USD","LU0158827781.USD","BK4514","BK4077","GOOGL","IE0034235188.USD","BK4532","LU0109391861.USD","LU0187121727.USD","IE00BKVL7J92.USD","LU0048573561.USD","LU0052756011.USD","IE0004086264.USD","IE00BK4W5L77.USD","LU0130103400.USD","BK4534","LU0127658192.USD","LU0149725797.USD","IE00BJTD4N35.SGD","IE0034235303.USD","LU0158827948.USD","LU0198837287.USD","LU0225283273.USD","LU0211327993.USD","BK4592","WGS","LU0211328371.USD","IE00BJLML261.HKD","LU0106261372.USD"],"gpt_icon":0},{"id":"2481120932","title":"Alphabet Ups Share Stake in Freshworks by 31.4% to 16.2 Mln Class a Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2481120932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481120932?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:10","pubTimestamp":1731064243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3MF1MH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0170899867.USD","IE00BJLML261.HKD","BK4576","IE0004091025.USD","LU0061474705.USD","IE00BWXC8680.SGD","BK4588","LU0128525689.USD","LU0149725797.USD","FRSH","BK4550","IE00BJTD4N35.SGD","LU0061475181.USD","BK4592","BK4505","LU0109391861.USD","LU0187121727.USD","BK4023","WGS","IE00BZ1G4Q59.USD","BK4581","BK4573","LU0234570918.USD","LU0029864427.USD","LU0158827781.USD","LU0006306889.USD","LU0109392836.USD","SNOW","LU0225283273.USD","BK4538","BK4535","LU0198837287.USD","BK4551","IE00BKVL7J92.USD","LU0106261372.USD","LU0158827948.USD","LU0056508442.USD","IE0004086264.USD","BK4534","BK4554","BK4077","LU0215105999.USD","LU0097036916.USD","IE00BJTD4V19.USD","BK4579","GOOGL","LU0061474960.USD","BK4574","LU0127658192.USD"],"gpt_icon":0},{"id":"2481120299","title":"Alphabet - Change in Holdings Are as of Sept 30, 2024 and Compared With the Previous Quarter Ended as of June 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481120299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481120299?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:10","pubTimestamp":1731064243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nFWN3MF1MH:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0127658192.USD","BK4585","IE00B1BXHZ80.USD","LU0109391861.USD","LU0211328371.USD","BK4503","LU0130518102.USD","BK4196","LU0198837287.USD","SNOW","BK4121","LU0128525929.USD","FRSH","BK4551","WGS","LU0061474960.USD","LU0052756011.USD","BK4579","LU0048573561.USD","LU0225283273.USD","BK4116","IE00BJTD4N35.SGD","IE00BK4W5M84.HKD","BK4527","IE00BJTD4V19.USD","ILMN","LU0077335932.USD","LU0056508442.USD","LU0234570918.USD","BK4514","BK4576","IE00BSNM7G36.USD","LU0048584097.USD","LU0061475181.USD","IE00BWXC8680.SGD","LU0006306889.USD","IE00BKDWB100.SGD","BK4535","BK4554","BK4538","BK4588","BK4581","LU0130102774.USD","GOOGL","LU0096364046.USD","LU0158827948.USD","BK4573","LU0097036916.USD","IE00B1XK9C88.USD","LU0106261372.USD"],"gpt_icon":0},{"id":"2481192067","title":"New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2481192067","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481192067?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:35","pubTimestamp":1731015300,"startTime":"0","endTime":"0","summary":"Data demonstrates the strength of GeneDx’s diverse database; exome diagnostic rate is high regardless of patient’s ancestral background. GeneDx industry leading dataset from 46% non-white populations. \"Our findings show that when people are tested, diagnostic rates among populations are comparable,\" said Mike Bamshad, MD, FACMG, Professor of Pediatrics at the University of Washington and Seattle Children’s Hospital. \"Nevertheless, considerable disparities in access to testing remain. We, and our collaborators at GeneDx, are testing a variety of novel ways to simplify clinical workflows, increase provider readiness, and ultimately reduce barriers to genetic testing.\". The study was constructed using GeneDx’s industry leading diverse dataset of more than 700,000 clinical exome and genomes. The data was presented this week at the American Society of Human Genetics  annual meeting. GeneDx leverages its database as a critical tool to drive transformational care for pediatric patients and as","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/QzGy6rYIZRa4JUet73y6sg--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3f2df91a430448db75b2db9de45268bf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/QzGy6rYIZRa4JUet73y6sg--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3f2df91a430448db75b2db9de45268bf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-study-reveals-racial-disparities-213500747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","WGSWW","GENE","WGS","BK4196"],"gpt_icon":0},{"id":"2481856726","title":"Zacks.com featured highlights include Snap, GeneDx and Leonardo","url":"https://stock-news.laohu8.com/highlight/detail?id=2481856726","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481856726?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:46","pubTimestamp":1730814360,"startTime":"0","endTime":"0","summary":"Chicago, IL – November 5, 2024 – Stocks in this week’s article are Snap Inc. SNAP, GeneDx Holdings Corp. WGS and Leonardo DRS, Inc. DRS.3 Stocks to Buy on Earnings Acceleration in November. November has traditionally been one of the best months for stocks. This year, it won't be any different. Interest rate cuts and a rise in consumer outlays may trounce short-term gyrations in the stock market due to the upcoming presidential election. Thus, investors should capitalize on the positive trend by investing in earnings acceleration stocks.This is because studies have shown that most successful stocks have seen an acceleration in earnings before an uptick in the stock price. To that end, stocks like Snap Inc., GeneDx Holdings Corp. and Leonardo DRS, Inc. are exhibiting solid earnings acceleration.Earnings acceleration is the incremental growth in a company's earnings per share . In other words, if a company's quarter-over-quarter earnings growth rate increases within a stipulated time fram","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8DL4Urc.vcUKmmhh1cXSgg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8DL4Urc.vcUKmmhh1cXSgg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-snap-134600796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DRS","BK4196","BK4077","BK4187","WGSWW","WGS","BK4554","SNAP","BK4508","BK4551","BK4576"],"gpt_icon":0},{"id":"2481550852","title":"GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2481550852","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481550852?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:35","pubTimestamp":1730756100,"startTime":"0","endTime":"0","summary":"Data to be presented showcasing GeneDx’s ongoing commitment to spearheading industry-leading research to drive transformational clinical utility. STAMFORD, Conn., November 04, 2024----GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at the 2024 American Society of Human Genetics  annual meeting. GeneDx data will be presented across six platform presentations and five posters and will unveil findings from key research initiatives constructed on the backbones of its industry leading diverse dataset of more than 700,000 clinical exome and genomes.GeneDx leverages its database as a critical tool in a number of studies to drive transformational clinical care for pediatric patients as the industry continues to look for strong evidence to expand the utilization and clinical utility of genome sequencing. Through these strategic collaborations with SeqFirst, The University of Washington, PacBio the Autism Sequencing ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6N9tmUgFu4LFJ05FtNRtsg--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/b3f10f93e3c5f1cf0cb6384fa83f96cf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6N9tmUgFu4LFJ05FtNRtsg--~B/aD00MTc7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/b3f10f93e3c5f1cf0cb6384fa83f96cf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-highlight-key-research-findings-213500992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4107","BK4196","WGS","BK4117","WGSWW","AFG"],"gpt_icon":0},{"id":"2481568836","title":"3 Stocks to Buy for Stellar Earnings Acceleration in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2481568836","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481568836?lang=en_us&edition=fundamental","pubTime":"2024-11-05 04:05","pubTimestamp":1730750700,"startTime":"0","endTime":"0","summary":"November has traditionally been one of the best months for stocks. This year, it won’t be any different. Interest rate cuts and a rise in consumer outlays may trounce short-term gyrations in the stock market due to the upcoming presidential election. Thus, investors should capitalize on the positive trend by investing in earnings acceleration stocks.This is because studies have shown that most successful stocks have seen an acceleration in earnings before an uptick in the stock price. To that end, stocks like Snap Inc. SNAP, GeneDx Holdings Corp. WGS and Leonardo DRS, Inc. DRS are exhibiting solid earnings acceleration.In the case of earnings growth, you pay for something that is already reflected in the stock price. However, earnings acceleration helps spot stocks that haven’t yet caught the attention of investors and, once secured, will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/U45CrReyOBmRPBdkCWGGVw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/742c2718f9ff3a297d02254acce5007b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/U45CrReyOBmRPBdkCWGGVw--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/742c2718f9ff3a297d02254acce5007b"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-stocks-buy-stellar-earnings-200500663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DRS","WGSWW","WGS","SNAP"],"gpt_icon":0},{"id":"2480004623","title":"ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry","url":"https://stock-news.laohu8.com/highlight/detail?id=2480004623","media":"GlobeNewswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480004623?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:00","pubTimestamp":1730725200,"startTime":"0","endTime":"0","summary":"Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights. GARDEN CITY, NY, Nov. 04, 2024  -- ProPhase Labs, Inc.  , a next generation biotech, genomics, and diagnostics company, today announced the launch of DNA Complete, Inc., a wholly owned subsidiary, offering a groundbreaking direct-to-consumer DNA test that sequences virtually 100% of a customer’s genome. This new service provides customers with in-depth insights into health, wellness, and ancestry.DNA Complete – A New Paradigm in Direct-to-Consumer DNA Testing. Comprehensive Whole Genome Sequencing: Unlike traditional DNA Ancestry tests that analyze small snippets of DNA, DNA Complete offers a full genomic view, empowering customers with detailed health and wellness information alongside enhanced ancestry data.Competitive Pricing and Robust Platform: DNA Complete is designed to offer a robust genetic user platform at competitive pricing which makes advanced genomic insigh","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FgqiquHfSZVyKnxn7TUcEA--~B/aD04OTt3PTMwOTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/d2ea9d8ce2d6866e744a67f00b1096ec","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FgqiquHfSZVyKnxn7TUcEA--~B/aD04OTt3PTMwOTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/d2ea9d8ce2d6866e744a67f00b1096ec"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prophase-labs-launches-dna-complete-130000165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DTC","WGS","BK4196","PRPH","BK4007","GENE","DNA","BK4190","BK4121","BK4109","BK4139"],"gpt_icon":1},{"id":"2479908379","title":"Viasat to Deliver Dual-Band Global Aero Terminals for Embraer C-390 Multi-Mission Airlifter","url":"https://stock-news.laohu8.com/highlight/detail?id=2479908379","media":"PR Newswire","labels":["Company Corporation","Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479908379?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:00","pubTimestamp":1730376000,"startTime":"0","endTime":"0","summary":"Viasat's multi-band, multi-orbit, multi-network terminals will be integrated into Embraer C-390 Millennium aircraft. Viasat will work with Embraer to deliver its flexible HSA solution and support terminal integration on the C-390 aircraft. The integration of Viasat's hybrid capability addresses the requirement for differentiated and resilient SATCOM solutions to support the rapidly evolving missions of current and future global defense customers.The Viasat HSA is designed with an open architecture to support agile and resilient communications, allowing flexible terminal integration to enable, according to each customer operational needs, multi-band, multi-orbit connectivity on Viasat's networks, third-party networks, and access to private government networks including the Wideband Global SATCOM  network.The dual-band  broadband terminal integration on C-390 will offer to the global defense market an expandable, highly flexible, multi-network, multi-band, and multi-orbit SATCOM capabili","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.3bqQjedk2TFudiRj1BR3A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/164f020ec11f5ec7482f5592e025e674","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.3bqQjedk2TFudiRj1BR3A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/164f020ec11f5ec7482f5592e025e674"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/viasat-deliver-dual-band-global-120000064.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viasat-deliver-dual-band-global-120000064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation,Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BK4187","WGS","BK4020","ERJ","VSAT","LU0823046494.USD","LU0823046577.USD"],"gpt_icon":1},{"id":"2479658577","title":"Azenta receives regulatory approval for long-read WGS test","url":"https://stock-news.laohu8.com/highlight/detail?id=2479658577","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479658577?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:43","pubTimestamp":1730321001,"startTime":"0","endTime":"0","summary":"Azenta (AZTA) announced the launch of a long-read Whole Genome Sequencing test for clinical applications. Azenta becomes the first commercial provi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/azenta-receives-regulatory-approval-for-long-read-wgs-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/azenta-receives-regulatory-approval-for-long-read-wgs-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0012050646.USD","LU1169589451.USD","AZTA","LU2065732104.USD","LU1169590202.USD","BK4147","BK4196","WGS","LU0106261612.USD","BK4121"],"gpt_icon":0},{"id":"2479750188","title":"Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2479750188","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479750188?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:05","pubTimestamp":1730318700,"startTime":"0","endTime":"0","summary":"BURLINGTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc.  today announced the launch of a long-read Whole Genome Sequencing  test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States.Azenta, Inc.  is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-l","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/G3TSwqf1jelnXGq.4UtQZg--~B/aD0zNDM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/eca4b6d42bc937924e1c3c142a8434ab","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/G3TSwqf1jelnXGq.4UtQZg--~B/aD0zNDM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/eca4b6d42bc937924e1c3c142a8434ab"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/azenta-obtains-regulatory-approval-clinical-200500173.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azenta-obtains-regulatory-approval-clinical-200500173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4147","LU0106261612.USD","LU1169589451.USD","BK4121","WGS","AZTA","BK4196","LU1169590202.USD","LU2065732104.USD","LU0012050646.USD"],"gpt_icon":0},{"id":"1199137654","title":"Stock Track | GeneDx Holdings Soars on Strong Q3 Results and Bright Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1199137654","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199137654?lang=en_us&edition=fundamental","pubTime":"2024-10-31 01:14","pubTimestamp":1730308469,"startTime":"0","endTime":"0","summary":"Shares of GeneDx Holdings  surged 5.62% on October 30, 2024, following the company's impressive third-quarter 2024 results and raised full-year guidance. The genetic testing firm reported significant revenue growth, margin expansion, and achieved profitability for the first time since its inception.GeneDx Holdings' revenue from continuing operations reached $76.6 million in the third quarter, a remarkable 52% increase year-over-year. This growth was primarily driven by strong demand for the comp","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WGS"],"gpt_icon":0},{"id":"1109659282","title":"Stock Track | GeneDx Soars on Surging Exome and Genome Testing Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1109659282","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109659282?lang=en_us&edition=fundamental","pubTime":"2024-10-30 21:42","pubTimestamp":1730295773,"startTime":"0","endTime":"0","summary":"Shares of GeneDx Holdings Corp. , a leading provider of exome and genome testing services, surged over 5% on Tuesday after the company reported exceptional third-quarter results and raised its full-year outlook, driven by rapidly increasing adoption of its genetic testing products.GeneDx delivered a blockbuster performance in Q3 2024, with revenues from continuing operations soaring 52% year-over-year to $76.6 million. The company's core exome and genome testing business fueled this growth, with","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | GeneDx Soars on Surging Exome and Genome Testing Growth","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WGS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":-0.0225},{"period":"1month","weight":0.2471},{"period":"3month","weight":1.0154},{"period":"6month","weight":2.4985},{"period":"1year","weight":50.1135},{"period":"ytd","weight":25.2073}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.22757},{"month":2,"riseRate":1,"avgChangeRate":0.478474},{"month":3,"riseRate":0.25,"avgChangeRate":-0.131493},{"month":4,"riseRate":0.25,"avgChangeRate":0.057396},{"month":5,"riseRate":0.25,"avgChangeRate":-0.033789},{"month":6,"riseRate":0.5,"avgChangeRate":-0.037543},{"month":7,"riseRate":0.75,"avgChangeRate":0.146466},{"month":8,"riseRate":0,"avgChangeRate":-0.237867},{"month":9,"riseRate":0.25,"avgChangeRate":-0.04851},{"month":10,"riseRate":0.75,"avgChangeRate":0.168214},{"month":11,"riseRate":0,"avgChangeRate":-0.237062},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011354}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction